Physical therapy rehabilitation solutions are used for managing musculoskeletal pain and improving overall mobility of patients. These include ultrasound therapy, electrical stimulation therapy, laser therapy, and traction therapy which provides relief from muscle spasms, joint stiffness, and pain. The global Physical Therapy Rehabilitation Solutions Market is estimated to be valued at US$ 28.86 Billion in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends: One of the key trends driving the growth of the physical therapy rehabilitation solutions market is the increasing demand for pain management solutions. With rising incidences of sports injuries, road accidents, and age-related health conditions, there is a growing need for effective pain relief therapies. Physical therapy rehabilitation solutions help in managing chronic and acute pain through non-invasive methods. The various therapies provided reduce inflammation and stimulate tissue healing to provide relief from pain. This has increased the adoption of these solutions among healthcare facilities and patients. Moreover, growing awareness about the benefit of physical therapies for pain management compared to pharmaceutical drugs is further boosting the demand in the market.
Segment Analysis
The global physical therapy rehabilitation solutions market is dominated by the orthopedic care sub segment. Being one of the most common forms of physical therapy, orthopedic care accounts for nearly 30% of the overall market share. It treats musculoskeletal conditions affecting muscles, bones and joints through modalities like strength training, massage, electromagnetic therapy and hydrotherapy. The growing geriatric population worldwide which is more susceptible to orthopedic disorders like arthritis is a major driver for the growth of this sub segment.

Key Takeaways
The Global Physical Therapy Rehabilitation Solutions Market is expected to witness high growth over the forecast period of 2023 to 2030.

Regional Analysis
North America currently accounts for the largest share of around 40% of the global physical therapy rehabilitation solutions market due to rising healthcare expenditure and advanced physical therapy infrastructure in the region. However, the Asia Pacific region is expected to grow at the fastest pace over the coming years driven by large patient pools, increasing medical tourism and investments towards developing sophisticated physical therapy establishments especially in China, India and Japan.

Key Players
Key players operating in the physical therapy rehabilitation solutions market include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.

Get more insights on this topic: http://marketerefforts.weebly.com/home/physical-therapy-rehabilitation-solutions-market-is-estimated-to-witness-high-growth-owing-to-opportunity-of-the-rising-geriatric-population